PharVision Advisers’s Armour Residential REIT ARR Stock Holding History

PharVision Advisers’s Portfolio ARR Stock Details ARR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,979	Closed	-$164K	–	697
2025 Q3	$164K	Buy	+10,979	New	+$172K	0.09%	554

Other funds holding ARR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PharVision Advisers's ARR Position: Q4 2025 in Review

PharVision Advisers sold out of Armour Residential REIT (ARR) in Q4 2025, closing a stake of 10,979 shares — an estimated $164K sold.

PharVision Advisers first reported a position in ARR in Q3 2025 and held it in 1 quarter. The position peaked at $164K in Q3 2025. 221 funds tracked by Wall St. Rank hold ARR as of Q4 2025.

PharVision Advisers reported no remaining Armour Residential REIT position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 10,979 Armour Residential REIT shares in Q4 2025, an estimated $164K.
PharVision Advisers first reported a position in Armour Residential REIT in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Armour Residential REIT position peaked at $164K in Q3 2025.
221 funds tracked by Wall St. Rank held Armour Residential REIT as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.